Further, in ER+/HER2+ breast xenograft models complete tumor eradication depended on concurrent blockade of ER together with anti-HER2 therapy6–8, since uninhibited ER can transmit alternative survival and proliferative signals to evade HER2 blockade. This evidence concerns the gene ERBB2 and neoplasm.